DEERFIELD BEACH, Fla. and NAPOLEONVILLE, La., May 30, 2007 (PRIME NEWSWIRE) -- Red Reef Laboratories International, Inc. (Pink Sheets:RRLB), a scientific research, development, and marketing group focused on commercializing a variety of chemical and biological products, today announced that the Company has opened its first sales office in the Chinese city of Guangzhou. This significant step forward marks the start of the Company's efforts to distribute Red Reef Laboratories International, Inc.'s keynote product, BioClear(r) FF Poultry and Swine Premise Disinfectant Cleaner in conjunction with Benchmark China Ltd., a consulting and investment management firm offering services to American and Chinese businesses seeking to do business in China and the United States. BioClear(r) FF is a phosphate-free formula with broad spectrum of virucidal and biocidal cleansing agent characteristics, providing easier application and safer use. As an environmental decontamination agent, BioClear(r) FF can be applied liberally in farm environs as well as in animal quarters, farm buildings, and residences.
The BioClear(r) FF product is easy to apply: it can be sprayed, fogged, wiped on, or applied in any manner that is convenient to the user for his specific application, and each form of application is equally effective. No special precautions are required for storage and no procedures required after application. As both Red Reef Laboratories International, Inc. and Benchmark China Ltd. gain experience and acceptance within the Asian marketplace, the companies intend to expand the product offering with additional Red Reef BioClear(R) surface decontaminant products.
With the new China headquarters established and personnel engaged, Red Reef will immediately apply to the Government for sales in China, as the company concurrently prepares to execute its marketing strategy and selling tools. The Company expects to promptly receive governmental permission to sell its products.
Red Reef chose to establish a footprint in the Chinese market because of the recent concerns surrounding Asian influenza (also known as Avian Bird Flu). The primary market for BioClear(r) will be poultry and turkey farms, egg processing plants, meat and poultry producing establishments and any other business and/or site where Avian Bird Flu may be of a concern. Although it is generally accepted that the virus is transmitted from bird to bird and bird to human as an airborne disease, the Company believes precautions should be taken at every level of sanitation as well.
About Red Reef Laboratories International, Inc.:
Red Reef Laboratories International, Inc. is a scientific research, development, and marketing group established to assemble, develop, commercialize and bring to market a variety of chemical and biological products, utilizing advanced surfactant technology and increasingly "green" compounds. These series of products are specifically designed for biocidal and virucidal applications. For more information, please visit the Company's web site at www.redreef.biz.
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: With the exception of historical information, the statements set forth above include forward-looking statements that involve risk and uncertainties. The Company wishes to caution readers that a number of important factors could cause actual results to differ materially from those in the forward-looking statements. Those factors include, but are not limited to, the risk factors noted in the Company's filings with the United States Securities and Exchange Commission, such as the rapidly changing nature of technology, evolving industry standards and frequent introductions of new products, services and enhancements by competitors; the competitive nature of the markets for the Company's products and services; the Company's ability to gain market acceptance for its products and services; the Company's ability to fund its operational growth; the Company's ability to attract and retain skilled personnel; the Company's ability to diversify its revenue streams and customer concentrations; and the Company's reliance on third-party suppliers.